Presence of somatomedin receptors on primary human breast and colon carcinomas.
about
Analogues of luteinizing hormone-releasing hormone containing cytotoxic groupsModulation of insulin-like growth factor-1 receptor and its signaling network for the treatment of cancer: current status and future perspectivesThe Novel Functions of High-Molecular-Mass Complexes Containing Insulin Receptor Substrates in Mediation and Modulation of Insulin-Like Activities: Emerging Concept of Diverse Functions by IRS-Associated ProteinsInsulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studiesSugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance)A novel glycoengineered bispecific antibody format for targeted inhibition of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor type I (IGF-1R) demonstrating unique molecular properties.Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approachInsulin-like growth factors and neoplasia.Beyond standard adjuvant therapy for colon cancer: role of nonstandard interventionsInsulin-like growth factor 1 receptors in human breast tumour: localisation and quantification by histo-autoradiographic analysis.IGF-IR in patients with advanced colorectal cancer in correlation with certain clinico-morphological factors: Initial reportThe role of obesity in cancer survival and recurrence.A method for evaluation of activity of antagonistic analogs of growth hormone-releasing hormone in a superfusion system.Molecular imaging of insulin-like growth factor 1 receptor in cancer.Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803Insulinlike growth factors in human malignancy.Inducing apoptosis of human colon cancer cells by an IGF-I D domain analogue peptide.Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers.Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin.Horizon scanning for novel therapeutics for the treatment of prostate cancer.Roles of hormones and signaling molecules in describing the relationship between obesity and colon cancer.A review of body size and breast cancer risk in Hispanic and African American women.Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy.Diabetes mellitus is an independent risk factor for colorectal cancer.Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice.IGF1R Protein Expression Is Not Associated with Differential Benefit to Concurrent Trastuzumab in Early-Stage HER2+ Breast Cancer from the North Central Cancer Treatment Group (Alliance) Adjuvant Trastuzumab Trial N9831.Transcriptional activation of the porcine P450 11A insulin-like growth factor response element in MCF-7 breast cancer cells.Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosisInsulin-like growth factor 1 receptor inhibitors: where do we come from? What are we? Where are we going?Colonic neoplasia in acromegaly: increased proliferation or deceased apoptosis?
P2860
Q24324532-C9D65A94-5973-4C29-AE20-605F6E00C91CQ26852578-A4A5B06D-1A0C-468C-A216-269B1F625C86Q28088661-C3B2A3E5-E5DC-40B1-97FD-D32D40D21AF6Q33578887-38DB322D-9E9B-4982-942C-265F24210F17Q33768908-B17293B7-8CB7-48D8-99A1-56D98E96F39BQ33846405-EEA79F65-CBB4-4472-AD1E-975F918B8A64Q33925323-F99FF5BF-5B5F-4436-8BFD-EA5482A6FED7Q34330521-2E4B0FB3-A438-43AF-8FB1-68D73C653419Q35147929-D2FC44AA-3407-4D2B-B96E-A04E4C9612C4Q35994133-733DB0A9-01D2-460A-89BB-8C9F16E7EABDQ36121569-A5E807C1-826A-47AA-9386-EF199218A43FQ36152955-7972E2CC-B6C1-47A0-B3B2-6A126A84B233Q36157690-2593A5E9-FD14-4168-8548-8F796CFB5888Q36337268-EC7D72B7-79C3-47F1-9244-DB42A657F5D4Q36411742-8CB287F4-63DA-4A97-8172-B8D86804D91AQ36418856-8A40950B-B3B4-46A8-B685-336CF9828198Q36512572-CC5F5354-22A2-4C32-ADED-8ADAD9A838B8Q36641767-A8164534-B9BA-4B66-8826-0E88BF8A55A1Q37125053-B3B8F01D-7D7B-4AD2-98BF-1DAE4A38C290Q37750871-AAAC7905-BEB1-4719-B44B-8065368706B5Q37792060-7AC00CF9-77B9-4DB2-AC69-D668B13C22D3Q37827415-C7B41DCD-FB39-46D1-8BE6-E24D504DFC5DQ37877651-79DC7729-A405-4A6E-A593-D5557B670F38Q37975246-B3916098-5C61-47CB-AD68-49B8C9F7AFAFQ37981088-F3DC101E-383A-4D24-B133-2096D562E0EEQ38311441-81B747F5-15CA-4A28-9785-0752DBF158B4Q38770018-59B225BE-96E5-4FF6-B09D-F7DCF1F83653Q39436874-213FB518-2667-4E4B-B239-1BEA220C2A02Q40020782-3D291A20-09F8-461F-A615-307FE9E5A409Q44582020-F0A3DE9F-584D-4957-84D9-C5FFA6BE184BQ51483688-F6DC0506-CE18-421E-AE8F-CE3345D3A9C7
P2860
Presence of somatomedin receptors on primary human breast and colon carcinomas.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Presence of somatomedin receptors on primary human breast and colon carcinomas.
@en
type
label
Presence of somatomedin receptors on primary human breast and colon carcinomas.
@en
prefLabel
Presence of somatomedin receptors on primary human breast and colon carcinomas.
@en
P2093
P1433
P1476
Presence of somatomedin receptors on primary human breast and colon carcinomas.
@en
P2093
P304
P356
10.1016/0304-3835(87)90218-7
P407
P577
1987-12-01T00:00:00Z